PATENT CLAIM ANALYSIS

Application Number: 16203654
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "093210"]

Abstract:
Disclosed herein is a method for manufacturing a population of human insulin producing cells from non-pancreatic β-cells, wherein the resulting insulin producing cells have increased insulin content, or increased glucose regulated secretion of insulin, or a combination of both.

Claim (Index 8):
The method of  claim 1 , wherein collecting the propagated and expanded cells at the end of each passage, comprises harvesting cells at a density of about 1\u00d710 4 -5\u00d710 4  cells/cm 2 .

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.43333
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14983657', '14897262', '14330965', '10843801', '10113118']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7646525714523156
- 35 USC 102 Novelty (BERT): 0.6240977684581762
- Combined Prediction Score: 0.7505970911529016
- Mean Citation Score: 516.661872
- Max Citation Score: 831.7019700000003
- Similarity Product: 491.3549883497609

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test